The Environmental Defense Fund has injected a decisive argument into the debate over reforming the Toxic Substances Control Act, insisting that American chemical safety decisions must rest on American data, not the regulatory approvals of other nations. In a blog post published on August 27, 2026, EDF directly challenges a frequently proposed shortcut in chemical regulation: the idea that if a new chemical has been approved by a foreign regulator, the U.S. Environmental Protection Agency should expedite or automatically accept that decision. The group argues that such an approach, while superficially appealing for its efficiency, fundamentally misunderstands how chemical risk actually works. The risk of a chemical, EDF explains, is not an intrinsic property of the molecule itself but emerges from the specific context of its use, the people exposed, the duration and magnitude of that exposure, and the protective measures in place. Because these conditions vary dramatically from country to country, an approval in one jurisdiction offers little meaningful assurance for another. This position arrives at a critical moment, as both the House and Senate have held hearings in 2026 on discussion drafts of legislation that would amend TSCA, the primary federal law governing the manufacture and import of industrial chemicals in the United States.
EDF’s blog post draws directly on the experience and conclusions of the Organisation for Economic Co-operation and Development, an international body that has spent years examining whether countries could systematically accept each other’s risk-based new chemical decisions. The OECD’s New Chemicals Task Force, according to EDF, identified fundamental challenges to such automatic mutual recognition and ultimately walked away from the concept. The task force concluded that new chemical risk-based decisions are too dependent on country-specific conditions to be automatically adopted by another jurisdiction. This ruling from an organization built to harmonize international policy carries significant weight, and EDF is leveraging it to argue that the U.S. Congress should reject any legislative language that would compel or encourage EPA to defer to foreign approvals.
Why Chemical Risk Cannot Be Exported or Imported
The core of EDF’s argument rests on a deceptively simple principle: the hazard of a chemical is not the same as its risk. A chemical may be inherently toxic, but whether it actually causes harm depends entirely on how it is used, who uses it, how much they are exposed to, and for how long. A substance approved for use in a sealed, automated industrial process in Germany may pose unacceptably high risks if used in a small, poorly ventilated workshop in the United States. A chemical restricted in Canada because of specific worker safety protections that do not exist in the U.S. could create entirely different exposure profiles across the border. EDF emphasizes that the EPA must evaluate how a chemical will be produced and used in the United States before granting approval, rather than relying on another country’s determination.
This is not a purely theoretical concern. The U.S. chemical market is enormous and diverse, with production volumes, distribution channels, and downstream uses that differ substantially from those in Europe, Japan, or Australia. American workers are protected by the Occupational Safety and Health Administration, but OSHA’s permissible exposure limits for many chemicals are decades old and do not always reflect modern understanding of risk. Consumer exposure patterns in the U.S. — where products may be used in larger quantities, for longer periods, or by more vulnerable populations — can diverge sharply from those in other regions. EDF is effectively arguing that any legislative amendment to TSCA that attempts to fast-track approvals based on foreign decisions would risk importing risks that are invisible to a distant regulator.
The OECD’s Rejection of Mutual Recognition
The OECD’s New Chemicals Task Force examined the possibility of mutual acceptance of risk-based new chemical decisions, a concept that would allow a chemical approved in one member country to gain automatic or near-automatic approval in all others. On its face, the idea holds considerable appeal for industry, promising reduced regulatory burdens, faster time to market, and lower costs. But the task force identified fundamental challenges that ultimately made the concept impractical. EDF reports that the OECD concluded that new chemical risk-based decisions are too dependent on country-specific conditions to be automatically adopted by another jurisdiction. This finding is notable because the OECD has a strong track record of successful harmonization in other areas, particularly in test method guidelines and good laboratory practices. The fact that even this pro-harmonization body could not make mutual recognition work for new chemical risk assessments speaks to the depth of the problem.
The implications for TSCA reform are direct. If the OECD itself has concluded that automatic adoption of another country’s risk-based decision is unworkable, then any legislative language that attempts to impose such a system on the EPA would be building on an intellectually and practically unsound foundation. EDF is essentially telling Congress that the shortcut being considered is a known dead end, already tested and rejected by the world’s leading international forum on chemical regulation.
The Congressional Debate on TSCA Modernization
EDF’s intervention comes against the backdrop of active legislative efforts in both chambers of Congress. The House Subcommittee on Environment and Climate Change held a hearing on January 27, 2026, focusing on legislation to modernize TSCA. The Senate Committee on Environment and Public Works followed with a hearing on March 6, 2026, examining a draft TSCA bill that specifically focused on new chemical review. The precise contents of these discussion drafts have not been fully disclosed, but the issues at stake are well understood. Since the 2016 Lautenberg amendments to TSCA, the EPA has been required to make affirmative safety determinations for all new chemicals before they can enter commerce. This mandate has dramatically changed the regulatory landscape, but it has also created significant challenges for the agency, which must review hundreds of new chemical notifications each year with limited resources.
Industry representatives have argued that the current process is too slow, too unpredictable, and too costly. They have pointed to the fact that other countries, particularly in Europe under the REACH regulation, often complete new chemical evaluations more quickly. The natural legislative response has been to explore mechanisms that would allow the EPA to leverage the work of foreign regulators, potentially through some form of expedited review for chemicals already approved in certain jurisdictions. EDF’s blog post directly targets this line of thinking, arguing that such a mechanism would be scientifically unsound and would undermine the very purpose of TSCA, which is to protect American health and the environment from unreasonable chemical risks.
What a Country-Specific Approach Means for EPA Review
EDF does not argue that the EPA should ignore foreign regulatory decisions entirely. Information from other jurisdictions can be valuable input, particularly when it comes to understanding a chemical’s intrinsic hazards, its physicochemical properties, or the results of toxicity testing. But EDF’s position is that such information must be supplemented with a thorough analysis of American conditions of use. The EPA would need to ask: How will this chemical be manufactured in the U.S.? What volumes will be produced? What types of worker exposure are expected? Will the chemical be used in consumer products, and if so, by whom and under what conditions? Are there existing regulatory requirements in the U.S. that would mitigate or exacerbate the risk? What protective equipment and engineering controls are typical in the relevant American industries?
These questions are not trivial. A chemical used as an intermediate in a closed industrial system in Germany might be used as a solvent in a consumer product sold on Amazon in the United States. A chemical that is handled only by trained professionals wearing full personal protective equipment in Japan might be used in an unregulated workshop in a small American town. The exposure scenarios are fundamentally different, and the risk assessments built on those scenarios must be different as well. EDF is effectively arguing that the EPA must conduct its own independent analysis of American conditions of use, and that delegation of this responsibility to a foreign regulator would be a dereliction of the agency’s statutory duty.
The Featured Snippet: A Clear Answer
Why did the OECD abandon the idea of mutual acceptance of new chemical risk-based regulatory decisions? The OECD New Chemicals Task Force identified fundamental challenges to automatically adopting another country’s risk-based new chemical decision. The task force concluded that such decisions are too dependent on country-specific conditions — including use patterns, exposure scenarios, worker protections, and regulatory requirements — to be reliably transferred between jurisdictions. The organization ultimately walked away from the concept, determining that the variability in national conditions makes automatic mutual recognition unworkable for new chemical approvals.
Practical Consequences for Industry and Regulators
For chemical manufacturers and importers, EDF’s position carries clear implications. Companies cannot expect that a foreign approval will serve as a ticket to the U.S. market. Each new chemical notification submitted to the EPA will continue to require a complete, country-specific analysis of conditions of use and potential exposures. This does not mean that foreign data is irrelevant — toxicity studies, physicochemical data, and other hazard information generated under OECD test guidelines will still be accepted and used. But the risk assessment that EPA builds on that data must reflect American realities. Companies should prepare to provide detailed information about their intended U.S. production volumes, manufacturing processes, worker exposure controls, downstream uses, and consumer access scenarios.
For the EPA, EDF’s argument supports the agency’s current practice of conducting independent new chemical reviews. The agency has long maintained that foreign approvals are not substitutes for its own assessments, and the OECD’s findings provide strong international support for that position. The practical challenge for the EPA will be managing its workload efficiently without compromising the depth of analysis required. The agency has already taken steps to streamline its new chemical review process, including the use of new approach methodologies and read-across techniques to reduce reliance on animal testing. But EDF’s blog post suggests that efficiency measures should focus on improving EPA’s own analytical capabilities, not on outsourcing decisions to foreign regulators.
The Broader Principle: National Sovereignty in Chemical Regulation
Underlying EDF’s argument is a fundamental question about the nature of chemical regulation in a globalized economy. The OECD’s rejection of mutual recognition for new chemical decisions reflects a broader tension between the desire for regulatory harmonization and the reality of national differences in industrial structure, worker protection, environmental conditions, and public health priorities. The chemical industry operates across borders, but the people and environments affected by chemical production and use are local. A factory in Louisiana is not a factory in the Netherlands; a household in Texas is not a household in Sweden. The conditions of use that determine risk are inherently place-based, and EDF is arguing that any regulatory system that ignores this reality is building on a false premise.
This principle has implications beyond TSCA. Similar debates are playing out in other areas of environmental regulation, including pesticide approvals, food safety standards, and air quality rules. The question of when and how to rely on foreign regulatory decisions is a recurring theme in modern governance, and the OECD’s experience with new chemicals provides a cautionary tale. EDF is effectively urging Congress to think carefully about the limits of regulatory borrowing and to recognize that some decisions must remain firmly within national jurisdiction.
Looking Forward: The Stakes for TSCA Reform
As the House and Senate continue to refine their TSCA reform proposals, EDF’s intervention will likely serve as a key reference point for environmental and public health advocates. The blog post provides a clear, evidence-based rationale for opposing any provision that would authorize or encourage automatic deference to foreign chemical approvals. It also offers a constructive alternative: that Congress should focus on providing EPA with the resources and tools needed to conduct thorough, efficient, and country-specific new chemical reviews, not on importing decisions made under fundamentally different conditions.
The OECD’s walk away from mutual recognition is not an argument against international cooperation. It is an argument for cooperation of the right kind — sharing data, harmonizing test methods, and comparing approaches, while preserving the authority of each nation to make its own risk-based decisions for its own population. EDF’s blog post makes a compelling case that American chemical safety decisions must be made for American conditions of use, and that any attempt to shortcut this process would undermine the very purpose of the Toxic Substances Control Act. For policymakers, the message is clear: when it comes to new chemical reviews, there is no substitute for doing the work yourself.
